Success! NASA's Maven Probe Goes Into Martian Orbit

NASA's Maven orbiter entered Martian orbit on Sunday after a journey of 10 months and 442 million miles, opening the way for a mission that could reveal what happened to the Red Planet's air and water.

The $671 million mission is designed to study Mars' upper atmosphere for one Earth year. But if Sunday's engine firing had gone awry, all that money and work would have gone for nothing. Fortunately, the bus-sized spacecraft's six rocket engines did the job, although mission managers reported that it took slightly longer than the planned 33 minutes.

Because of the distance between Earth and Mars, the readings confirming a successful burn were received at Maven's mission control center near Denver about 12.5 minutes after the spacecraft shut down the engine. Team members had brought peanuts and Mars candy bars to the Lockheed Martin facility as good-luck treats.

"Congratulations, Maven is now in Mars orbit," Dave Folta, mission design and navigation lead, told the team. That long-awaited word sparked an eruption of applause and hugs.

The University of Colorado's Bruce Jakosky, principal investigator for the Maven mission, noted that it's taken 11 years of planning to get the spacecraft to Mars. "I think my heart's about ready to start again," he said during a post-burn news briefing.

Sunday's maneuver put Maven into a highly elliptical pole-to-pole orbit, ranging in altitude from 236 miles to 27,700 miles (380 kilometers to 44,600 kilometers). Over the next several weeks, additional maneuvers will put the spacecraft into the prescribed orbit for its science mission, which will range as close as 77 miles (125 kilometers).

Maven's name comes from an acronym that stands for Mars Atmosphere and Volatile EvolutioN. The spacecraft's observations are expected to help scientists figure out how Mars lost most of its atmosphere over the course of billions of years a phenomenon that turned it from a world with liquid water that could have sustained life to the cold, dry planet we see today. Mars' current atmosphere, dominated by carbon dioxide, is only 1 percent as dense as Earth's.

Scientists suspect that storms of charged particles from the sun stripped off molecules from the upper atmosphere. Maven will measure the current rate of atmospheric loss valuable data that will be factored into computerized climate models for Mars.

"We measure these things today even though the processes we're interested in operated billions of years ago," Jakosky explained during a briefing last week.

Maven won't just be answering questions about ancient Mars. The planet appears to be going through an upswing in dust storms, said Richard Zurek, chief scientist for the Mars Program Office at NASA's Jet Propulsion Laboratory. Maven is arriving "just in time to see the imprint of that on the atmosphere of Mars," Zurek said during a Planetary Society webcast.

More:

Success! NASA's Maven Probe Goes Into Martian Orbit

S'pore to launch six satellites next year

Feng Zengkun

The Straits Times

Publication Date : 22-09-2014

In the next few years, tiny ears and eyes in the sky, built and manned by Singapore engineers, could help to track ships and planes, and stop piracy and illegal fishing.

The satellites will collect weather and climate change data, and monitor the Earth's environment by, say, mapping changes in river courses and catching firms that are cutting down trees illegally.

Some of them will even help make Global Positioning Systems (GPS) more accurate, and test state-of-the-art encryption technology to keep communications secure. A record six Singapore satellites are expected to launch from an island in India next year to do some of these tasks.

ST Electronics, ST Engineering's electronics arm, is launching one, the National University of Singapore (NUS) will put two into the sky, while Nanyang Technological University (NTU) will have three.

American firm Spire, which set up a Singapore office last month, will also have at least 20 nano-satellites in the air by next year to collect data.

The firm, which has raised US$25 million, plans to hire at least 100 people for the office here in the next five years. They will help to research and build hardware and software for the satellites, assemble and test them, and analyse the data collected.

See the original post:

S'pore to launch six satellites next year

Research Findings Demonstrate miRagen Therapeutics Synthetic microRNA-29 Mimic (promiR-29) Reverses Pulmonary Fibrosis

BOULDER, Colo.--(BUSINESS WIRE)--miRagen Therapeutics, Inc., a biopharmaceutical company developing innovative microRNA-based therapeutics, announced today that findings from a research collaboration between the Company and Yale University have demonstrated that promiR-29 reversed fibrosis in a mouse model of pulmonary fibrosis. These findings were published in the journal EMBO Molecular Medicine http://onlinelibrary.wiley.com/doi/10.15252/emmm.201303604/full on September 19, 2014.

The mimic, when injected into the blood, goes to the lung and it has a sustained effect. We are very impressed that it can reverse fibrosis, not only prevent it, said Naftali Kaminski, M.D., a professor at Yale School of Medicine and section chief of pulmonary, critical care and sleep medicine and a corresponding author of the study.

Results from the collaborative research conducted by miRagen and Yale have led to the award of a Centers for Advanced Diagnostics and Experimental Therapeutics in Lung Diseases Stage II grant from the National Institutes of Health to further evaluate this potential therapeutic approach.

miRagen is committed to translating these pre-clinical findings into transformative therapies for patients with Idiopathic Pulmonary Fibrosis, said Dr. David Rodman, Executive Vice President of Research and Development at miRagen Therapeutics, Inc. We are excited about the collaboration with Dr. Kaminski and by the potential for accelerated progression to human clinical trials afforded by the CADET II grant award.

About microRNAs

MicroRNAs have emerged as an important class of small RNAs encoded in the genome, acting as master regulators of gene expression. Recent studies have indicated that microRNAs appear to be associated with many disease processes. Because they are thought to be single molecular entities that dictate the expression of fundamental regulatory pathways, microRNAs represent potential drug targets for controlling many biologic and disease processes.1

About microRNA-29

The microRNA-29 family is a well-established regulator of extracellular matrix genes. The expression of the three family members is consistently down-regulated in a number of pathological fibrotic conditions, including cardiac, renal, hepatic, and pulmonary fibrosis, as well as systemic sclerosis2,3,4,5. Numerous studies in cell-culture and genetic replacement in rodents have also demonstrated the potential of miR-29 normalization to correct many drivers of pathological fibrosis.

About miRagen Therapeutics, Inc.

miRagen Therapeutics, Inc., is a biopharmaceutical company focused on the discovery and development of innovative microRNA (miRNA)-targeting therapies in disease areas of high unmet medical need. The Company seeks to leverage in-house expertise in miRNA biology, oligonucleotide chemistry, and drug development to evaluate and advance promising technologies and high-potential product candidates for its own pipeline and in conjunction with strategic collaborators. For certain cardiovascular disease programs, miRagen has a collaboration and license agreement with Servier, an independent French research-based pharmaceutical company. miRagen retains all rights for the Servier-partnered programs in the U.S. and Japan. For more information, please visit http://www.miragenrx.com.

See the original post here:

Research Findings Demonstrate miRagen Therapeutics Synthetic microRNA-29 Mimic (promiR-29) Reverses Pulmonary Fibrosis

Cloud Storage Users Share Pros and Cons of Leading Services

Picking the best service for your organization can be a challenge, but this guide will help determine which cloud service is right for you.

Today's cloud storage/file-sync space is constantly evolving.

The recent market gyrations may have you wondering if you should switch to another provider. With that in mind, we conducted an informal poll and asked cloud storage users for their opinions on the benefits and drawbacks of their services of choice.

The majority of respondents told us about their likes and dislikes of Dropbox (which earned six favorable mentions); Box (the favorite of five respondents); Google Drive (favored by four); and OneDrive (the recipient of four votes). Some participants use more than one service. A few other respondents chose lesser-known services, which you can read about in the "Cloud Storage Alternatives" section of this story.

We also put together an at-a-glance chart (below) that provides a quick comparison of the major cloud service providers.

Pros and Cons of Popular Cloud Services

Dropbox

Pros: "We went with Dropbox because of its ease of signing up," says Jerry Lee, founder of StoryLeather. "Plus, a lot of the freelance contractors we work with are already using Dropbox, so this created less friction to share files with them. More importantly, Dropbox was more vendor-neutral,' whereasin order to use Google Drive you have to have Gmail." Lee says OneDrive similarly requires a Microsoft account.

"Dropbox was a first-mover, and that's what drew us to them initially," says Ryan Matzner, director of app design and development firm Fueled. "What's kept us with them is how simple, hassle-free and easy-to-use the software is. Many members of our team are extremely tech-savvy, but a number aren't. And it's great that both kinds of users have little to no issues using Dropbox's website, desktop app and mobile apps."

So many people have Dropbox, and that makes sharing with them easy, according to Raymond Selzer, co-founder and director of development of website design firm Interslice Designs. "For those without Dropbox, sharing is still very simple."

Read the rest here:

Cloud Storage Users Share Pros and Cons of Leading Services

Yahoo Acquires Bangalore-Based Bookpad, Makers Of Online File Editing And Collaboration Software Docspad

Is Yahoo working on its own online document creation and collaboration software? Thats the question whichimmediately comes to mind upon hearing news thatthe company has now picked up a Bangalore-based startup called Bookpad, makers of Docspad, a service aimed at developers looking to add document viewing, annotations and editing features within their own applications.

What differentiates Docspad from rivals like Google Docs, however,is that instead of being aimed at consumers looking to simply create or edit documents, spreadsheets, or slideshows fromthe web, then share those files and collaborate with others, Docspad is designed to bring a Google Docs-like ease-of-use to any other application a business may need, including things like applicant-tracking systems, conferencing solutions, learning management solutions, and more, co-founder and CEO Aditya Bandi explained in a recent blog post.

The deal is making waves throughout Indias tech community, and has been confirmedby The Economic Times, The Times of India, and others. TechCrunch has also nowheard from sources that the deal has gone through. Bandi declined to comment, but its worth pointing out he has already changed his LinkedIn profile to reflect his new position as Product Manager at Yahoo.

Terms of the deal have not been disclosed, but Yahoo has the money to continue itsstartup shopping, thanks to its stake in Alibaba, which just ranked as the worlds biggest IPO. The Economic Times says via sources, the deal is clocking in at aroundRs 50 crore ($8.3 million).

Weve asked Yahoo for an official confirmation of the Bookpad deal, and are waiting to hear back.

UPDATE: Yahoo has confirmed, saying:

We have acquired Bookpad, the company behind the Docspad product. The team will join our communications organization in Bangalore, where they will work on strengthening the Yahoo Mail experience. Were excited for the expertise and knowledge that the team brings with them, and cant wait to get to work collaborating with them.

The startup was founded by three 20-something graduates from theIndian Institute of Technology (IIT) Guwahati Aditya Bandi, Niketh Sabbineni, and Ashwik Reddy. Last year, it was backed by NASSCOMs 10,000 Startups initiative and Microsoft Ventures. (NASSCOM, we hear, is already opening talking about the deal, too.)

According to The Economic Times, the Bookpad team met with Yahoo during a trip to Silicon Valley organized by NASSCOM. The report also noted that Yahoo wasnt the only suitor showing interest Autodesk and Dropbox were taking a look at the 8-person team, too.

Read the original:

Yahoo Acquires Bangalore-Based Bookpad, Makers Of Online File Editing And Collaboration Software Docspad

3rd International Conference on Tissue Science & Regenerative Medicine – Video


3rd International Conference on Tissue Science Regenerative Medicine
The 2014 OMICS Group Conference on 3rd International Conference on Tissue Science Regenerative Medicine which is going to be held during September 24-26, 2014 at Valencia, Spain will buckle-up...

By: omicsgroup incorporation

See the rest here:

3rd International Conference on Tissue Science & Regenerative Medicine - Video

MUHI Non-Communicable Disease (NCD) Panel – The Interface Of Law And Medicine – Video


MUHI Non-Communicable Disease (NCD) Panel - The Interface Of Law And Medicine
According to the WHO, 36 million deaths in 2008 were attributable to NCDs. The burden of NCDs is rising throughout the world as a result of multiple factors including health related risk factors,...

By: Melbourne University Health Initiative Inc.

Original post:

MUHI Non-Communicable Disease (NCD) Panel - The Interface Of Law And Medicine - Video

Construction Starts For Medical School In Chaffee Crossing

FORT SMITH(KFSM) Crews are preparing to break ground on a nearly $60 million medical school at Chaffee Crossing. Crews started moving dirt for the new medical school going up Monday (Sept.22). Leaders said its a project several months in the making.

The first building going up on campus will be the Osteopathic School followed by the Physicans Assistant School. Crews said the Osteopathic School will be three stories tall located on the west side of Chad Colley Boulevard. Once its up, theyll turn their attention to other areas on campus including several additional small buildings, a main entry for the school, and a pond.

Leaders said local companies are all teaming up to bring this medical school to the area. An investment from the Fort Smith Regional Healthcare Foundation is helping make it all happen, as well a grant of 200 acres from the Fort Chaffee Redevelopment Authority.

Executive Director Ivy Owen said its amazing watching the community pull together. That project is happening and its ahead of schedule, said Owen. According to Owen, As a matter of fact, by the fall of 2016 there will be a class in that medical school.

Even though crews are starting construction now, they wont have the official ground breaking ceremony for the medical school until the frame for the building goes next spring.

Once construction starts, crews said traffic will be re-routed to Taylor Avenue and Wells Lake. The medical school is set to open in the fall of 2016.

Read the original post:

Construction Starts For Medical School In Chaffee Crossing

MU School of Medicine announces new scholarships

Sep. 22, 2014 @ 12:00 AM

HUNTINGTON -- Six new scholarship have been created at the Marshall University Joan C. Edwards School of Medicine to assist students with tuition and other medical school expenses.

Linda Holmes, director of development and alumni affairs, thanked donors who are supporting the scholarships for their generous commitment and praised the two most recently graduated classes for endowing scholarships.

"These awards are designed to help students defray some of the costs associated with obtaining a medical education," Holmes said in a press release. "Our donors understand the financial burden that many of our students incur, and we are forever grateful that they are helping ease that burden."

The scholarships include:

The Sean K. and Beth L. Hammers Scholarship, once endowed, will be awarded to an entering medical student with first preference given to a resident of Lawrence County, Ohio, or Cabell County, West Virginia. Second preference will be given to a resident of West Virginia. This award is renewable for three additional years.

The Huntington Clinical Foundation MUJCESOM Expendable Scholarship is a gift of $30,000. A one-time, $10,000 scholarship will be awarded annually for three years to an entering first-year student. The MU JCESOM Scholarship Committee, in cooperation with the Office of Student Financial Assistance, will select the brightest, most academically gifted student for the award. The Huntington Clinical Foundation will review the recipient's qualifications before the award is offered.

The Joan C. Edwards School of Medicine Class of 2013 Endowed Scholarship will be awarded to a first-year medical student, and is renewable for three additional years. The recipient will be selected by the Scholarship Committee in cooperation with the Office of Student Financial Assistance.

The Joan C. Edwards School of Medicine Class of 2014 Endowed Scholarship will be awarded to a first-year medical student, and is renewable for three additional years. The recipient will be selected by the Scholarship Committee in cooperation with the Office of Student Financial Assistance.

The Mr. and Mrs. Guy C. Nangle Scholarship Fund has been established through a gift from the Mae E. Nangle Trust. The scholarship will be awarded to a Marshall University Joan C. Edwards School of Medicine medical student and is renewable.

Continued here:

MU School of Medicine announces new scholarships

Rep. DeLauro, school & medical staff to hold enterovirus briefing

NEW HAVEN, CT (WFSB) -

With a confirmed case of enterovirus-68 in Connecticut and potential cases still awaiting test results, doctors and schools have been getting flooded with calls and questions.

Rep. Rosa DeLauro, school officials and health experts held an informational briefing Monday.

"People need to take all the normal precautions they would take against the flu or any other virus," DeLauro said. "This is not a cause for panic, but we are seeing higher incidents of enterovirus this year and it can be particularly dangerous for children with asthma. So people need to have the facts and the tools to recognize the symptoms. I want to urge people to take all the normal precautions they would take against the flu or any other virus. If your children have trouble breathing or severe symptoms, contact a health professional."

The goal of the event was to answer questions like what to look for and how to treat the respiratory illness, then get the answers to school nurses so they can spot symptoms and pass information to parents.

Doctors said the virus typically affects children with asthma the most. They could experience wheezing, trouble breathing and blueness in the face. For most, the symptoms are similar to that of the common cold with a runny nose, coughing, sneezing and body aches.

If a child comes down with it, in most cases, they might not even know it.

"Couple of days they'll get better, and they - the parents - won't even know," said Dr. Richard Uluski, a pediatrician. "They'll go to school, have fun."

Parents and doctors alike have been cautions since health officials confirmed EV-68 at Yale-New Haven Children's Hospital last week.

Eyewitness News was told a 6-year-old with symptoms came to the hospital and was treated and released. It's the only confirmed case in the state so far, but a number of hospitals are still waiting to see if there will be more.

Read more here:

Rep. DeLauro, school & medical staff to hold enterovirus briefing